Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 180

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation

Open access
Min, Byeong Hyun, Devi, Shivani, Kwon, Goo Hyun, Gupta, Haripriya, Jeong, Jin-Ju, Sharma, Satya Priya, Won, Sung-Min, Oh, Ki-Kwang, Yoon, Sang Jun, Park, Hee Jin, Eom, Jung A, Jeong, Min Kyo, Hyun, Ji Ye, Stalin, Nattan, Park, Tae-Sik, Choi, Jieun, Lee, Do Yup, Han, Sang Hak, Kim, Dong Joon, Suk, Ki Tae · 2024 · Gut Microbes

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, and its prevalence has increased worldwide in recent years. Additionally, there is a close relationship between MASLD and gut microbiota-derived metabolites. However, the mechanisms of MASLD and its metabolites are still unclear. We demonstrated decreased indole-3-propionic acid (IPA) and indole-3-acetic acid (IAA) in the feces of patients with hepatic steatosis compared to healthy controls. Here, IPA and IAA administration ameliorated hepatic steatosis and inflammation in an animal model of WD-induced MASLD by suppressing the NF-κB signaling pathway through a reduction in endotoxin levels and inactivation of macrophages. Bifidobacterium bifidum metabolizes tryptophan to produce IAA, and B. bifidum effectively prevents hepatic steatosis and inflammation through the production of IAA. Our study demonstrates that IPA and IAA derived from the gut microbiota have novel preventive or therapeutic potential for MASLD treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19490976.2024.2307568

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Metadata

Authors
Min, B. H., Devi, S., Kwon, G. H., Gupta, H., Jeong, J.-J., Sharma, S. P., Won, S.-M., Oh, K.-K., Yoon, S. J., Park, H. J., Eom, J. A., Jeong, M. K., Hyun, J. Y., Stalin, N., Park, T.-S., Choi, J., Lee, D. Y., Han, S. H., Kim, D. J., & Suk, K. T.
Venue
Gut Microbes
Published
2024-02
Volume
16
Issue
1
Pages
2307568-2307568
ISSN
  • 1949-0976 (ISSN-L)
  • 1949-0984
OpenAlex
W4391447289
Cited by
180
References
13
FWCI
20.91
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation. https://app.cochat.ai/papers/10.1080/19490976.2024.2307568
The paper
Min, B. H., Devi, S., Kwon, G. H., Gupta, H., Jeong, J.-J., Sharma, S. P., Won, S.-M., Oh, K.-K., Yoon, S. J., Park, H. J., Eom, J. A., Jeong, M. K., Hyun, J. Y., Stalin, N., Park, T.-S., Choi, J., Lee, D. Y., Han, S. H., Kim, D. J., & Suk, K. T. (2024). Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation. Gut Microbes. https://doi.org/10.1080/19490976.2024.2307568

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.